comparemela.com

Page 5 - Rebecca Guntern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sandoz: Biosimilar Tyruko Gets Approval In Europe To Treat Multiple Sclerosis

Sandoz: Biosimilar Tyruko Gets Approval In Europe To Treat Multiple Sclerosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation

Biosimilar Hyrimoz® citrate-free high-concentration formulation is now approved in the EU for use in all indications of reference medicine Humira® HCF formulation adalimumab offers patients. | April 3, 2023

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.